← Back to Search

Behavioral Intervention

Machine Learning for Smoking Cessation

Waitlist Available
Led By Emily Hebert, DrPH
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
willingness to quit smoking 14 days after the baseline visit
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 4-weeks after quit day
Awards & highlights
Approved for 5 Other Conditions
All Individual Drugs Already Approved
No Placebo-Only Group

Study Summary

This trial will test how well a machine learning-based intervention can help people quit smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
You agree to stop smoking within 14 days after the first visit.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-weeks after quit day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-weeks after quit day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of patients who quit smoking as confirmed by absence of salivary cotinine

Awards & Highlights

Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Adaptive Treatment plus usual careExperimental Treatment4 Interventions
Group II: Usual careActive Control3 Interventions
First Studied
Drug Approval Stage
How many patients have taken this drug
FDA approved

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,433 Previous Clinical Trials
2,605,183 Total Patients Enrolled
The University of Texas Health Science Center, HoustonLead Sponsor
897 Previous Clinical Trials
318,792 Total Patients Enrolled
Emily Hebert, DrPHPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

Adaptive Treatment (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04839198 — N/A
Smoking Cessation Research Study Groups: Adaptive Treatment plus usual care, Usual care
Smoking Cessation Clinical Trial 2023: Adaptive Treatment Highlights & Side Effects. Trial Name: NCT04839198 — N/A
Adaptive Treatment (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04839198 — N/A
Smoking Cessation Patient Testimony for trial: Trial Name: NCT04839198 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still enrolling participants in this experiment?

"The latest data from clinicaltrials.gov reveals that this medical study, which was originally added to the database on November 1st 2021, is not presently looking for participants. Nevertheless, there are 214 alternative studies actively recruiting patients at present."

Answered by AI

How many individuals have been accepted into this research endeavor?

"At present, this research effort is not recruiting patients. It was initially posted on November 1st 2021 and edited most recently on September 27th 2021. For those interested in alternative studies, there are 143 trials needing participants to aid smoking cessation efforts and 71 adaptive treatment programs currently open for enrollment."

Answered by AI

Are there any previously conducted research projects associated with Adaptive Treatment?

"Currently, 71 Adaptive Treatment investigations are in progress and 5 have reached Phase 3. In particular, Greenville, South carolina is a hub for this type of research with 204 testing sites located there."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What site did they apply to?
The University of Texas Health Science Center at Houston
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

My grandkids and my health. I can go a few days without smoking then I give in not cause I’m craving so much but more of boredom.
PatientReceived 1 prior treatment

How responsive is this trial?

Typically responds via
Phone Call
~18 spots leftby Feb 2025